MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 229 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,740 | +15.0% | 24,174 | +43.0% | 0.00% | 0.0% |
| Q2 2023 | $210,191 | -11.3% | 16,910 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $236,909 | -5.9% | 16,910 | -3.9% | 0.00% | 0.0% |
| Q4 2022 | $251,770 | -32.5% | 17,594 | +20.5% | 0.00% | -50.0% |
| Q3 2022 | $373,000 | -10.1% | 14,606 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $415,000 | -28.8% | 14,606 | -11.6% | 0.00% | -33.3% |
| Q1 2022 | $583,000 | -3.0% | 16,529 | +15.2% | 0.00% | 0.0% |
| Q4 2021 | $601,000 | +31.5% | 14,352 | +54.1% | 0.00% | +50.0% |
| Q3 2021 | $457,000 | +17.5% | 9,312 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $389,000 | – | 9,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |